Spots Global Cancer Trial Database for hormone
Every month we try and update this database with for hormone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) | NCT01090765 | Prostate Cancer Metastatic Cast... | TRC105 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer | NCT00323882 | Prostate Cancer Neoplasm Metast... | MDX-010 | 18 Years - | Bristol-Myers Squibb | |
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas | NCT01556230 | Pituitary Adeno... Pituitary Tumor | Surgical interv... Radiotherapy fo... | 18 Years - | Columbia University | |
Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome | NCT03951077 | Polycystic Ovar... | Elagolix Placebo | 18 Years - 35 Years | AbbVie | |
Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast | NCT00943527 | Breast Cancer | 35 Years - 45 Years | Mayo Clinic | ||
C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma | NCT01530269 | Prostate Cancer Prostate Adenoc... | C11-Sodium Acet... | 18 Years - 90 Years | Phoenix Molecular Imaging | |
Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | NCT02678520 | Prostate Cancer | 3-D Conformal R... Intensity Modul... Casodex, Zolade... | 18 Years - | University of Kansas Medical Center | |
Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy | NCT00256698 | Breast Cancer | Fulvestrant Anastrozole | - | AstraZeneca | |
Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | NCT02678520 | Prostate Cancer | 3-D Conformal R... Intensity Modul... Casodex, Zolade... | 18 Years - | University of Kansas Medical Center | |
A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer | NCT00510718 | Prostate Cancer Hormone Refract... | MDV3100 | - | Pfizer | |
Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors | NCT00440089 | Breast Cancer | Hands-on-Healin... | 18 Years - 70 Years | University of California, San Diego | |
Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy | NCT00256698 | Breast Cancer | Fulvestrant Anastrozole | - | AstraZeneca | |
Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer. | NCT00757692 | Prostate Cancer | Vandetanib Bicalutamide | 18 Years - | British Columbia Cancer Agency | |
Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy | NCT00407251 | Hormone Refract... | Patupilone | 18 Years - | British Columbia Cancer Agency | |
A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer. | NCT01602380 | Hormone Recepto... | faslodex 500mg arimidex 1mg faslodex dummy arimidex dummy | 18 Years - 130 Years | AstraZeneca | |
Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer. | NCT00757692 | Prostate Cancer | Vandetanib Bicalutamide | 18 Years - | British Columbia Cancer Agency | |
Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors | NCT00440089 | Breast Cancer | Hands-on-Healin... | 18 Years - 70 Years | University of California, San Diego |